Dabur India has received directions from the NCLT to convene meetings of its equity shareholders and unsecured creditors regarding the merger with Sesa Care Private Limited. Sesa Care is a prominent player in the Ayurvedic hair oil segment with a paid-up capital of ₹966.50 crore. The merger, with an appointed date of April 1, 2026, aims to consolidate Dabur's market leadership by integrating Sesa's premium brand portfolio. This strategic move is expected to drive cost optimizations and distribution synergies across domestic and international markets.

ICRA Limited has reaffirmed the highest credit ratings for Dabur India Limited's debt instruments and bank facilities. The company's Rs 250 crore Non-Convertible Debentures (NCD) programme maintained its [ICRA]AAA (Stable) rating. Additionally, bank facilities totaling Rs 1,000 crore were reaffirmed at [ICRA]AAA (Stable) and [ICRA]A1+. This reaffirmation underscores Dabur's strong financial profile and high degree of safety regarding timely servicing of financial obligations.

Dabur India has announced its first investment through its 'Dabur Ventures' platform, acquiring a minority stake in luxury skincare D2C brand RAS Beauty for approximately Rs 60 Crore. RAS Beauty is a high-growth, digital-first company reporting a 3-year CAGR of 75% and an Annual Recurring Revenue (ARR) of nearly Rs 100 Crore. This strategic move marks Dabur's entry into the premium beauty segment, leveraging the target's high gross margins and 'Farm-to-Face' positioning. The investment will be used to scale RAS Beauty's omnichannel presence and R&D capabilities.

Dabur India has announced a strategic leadership restructuring to strengthen its domestic and international operations. Mr. Mohit Malhotra has been redesignated as the Global CEO, while Mr. Herjit S. Bhalla, an FMCG veteran with 25 years of experience, has been appointed as the CEO for the India Business effective April 15, 2026. Mr. Bhalla joins from The Hershey Company and has previously held leadership roles at Unilever and Metro Cash & Carry. This move signals Dabur's intent to scale its global footprint while bringing in specialized leadership for its core Indian market.

Dabur India reported a 6.1% YoY revenue growth for Q3 FY26, supported by a 6% growth in domestic FMCG and 3% volume growth. The Home & Personal Care (HPC) segment was a standout performer with 10.6% growth, while the Hair Oil portfolio surged 19.1% due to price hikes and market share gains. Despite a one-time labor law provision, PAT grew by 10.1% (7.2% adjusted), benefiting from cost-saving measures and rural markets outperforming urban areas. Management remains optimistic about sequential demand recovery and the modernization of legacy brands.

Dabur India reported a steady Q3 FY26 with consolidated revenue growing 6.1% YoY to ₹3,558.6 crore, supported by a 3% volume growth in the domestic FMCG business. Profit After Tax (before exceptional items) grew by 10.1% to ₹575 crore, showcasing margin expansion despite input cost pressures. The company faced one-time headwinds from the New Labour Code implementation and GST-related inventory liquidation in October. International business remained strong with 11.1% growth, while the Healthcare segment led domestic growth at 10.6%.

Dabur India reported a steady Q3 FY26 performance with consolidated revenue rising 6.1% YoY to ₹3,559 crore and net profit increasing 10.1% to ₹575 crore. The company demonstrated resilience with rural demand outperforming urban markets for the eighth consecutive quarter by a margin of 330 basis points. Significant market share gains were achieved in the Hair Oils and Juices categories, while the international business grew by 11.1%. Operating profit also saw a healthy growth of 7.7% despite input cost pressures.

Dabur India Limited reported a steady performance for the quarter ended December 31, 2025, with consolidated revenue growing 6.1% YoY to ₹3,558.65 crore. Net profit for the period increased by 7.3% to ₹553.61 crore, despite an exceptional charge of ₹15.05 crore. The core Consumer Care business remains the primary growth driver, contributing ₹3,064.46 crore to the topline, while the Food business saw a marginal decline. Overall, the company maintained stable margins with EPS rising to ₹3.16 from ₹2.95 YoY.

Dabur India expects its consolidated revenue for Q3 FY26 to grow in the mid-single digits, with operating profit and PAT projected to grow faster than revenue. The company is witnessing a demand recovery led by rural markets outperforming urban areas, further aided by recent GST rate revisions. While the Home & Personal Care segment is expected to post double-digit growth, the Healthcare segment is seeing sequential improvement with specific brands like Honitus growing over 15%. International operations are also showing strength, with near double-digit growth expected in INR terms.